Interestingly, a recent study suggests that ANP32E may be an independent prognostic marker for human breast cancers, where higher ANP32E protein levels are associated with the TNBC subtype and correlated with a shorter overall and disease-free survival. Here, ANP32E is linked to breast carcinoma.